Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Naho, Nishimoto"'
Autor:
Hiroko Hasegawa, Sena Higashi, Yuko Nishimura, Eiji Mita, Akio Ishihara, Yasuharu Kawamoto, Naho Nishimoto, Shoichi Nakazuru, Yusuke Seiki, Naoko Hayata, Yuko Sakakibara, Hiroshi Tsumuro, Shunsuke Yamamoto, Hiroki Bessho, Tetsuro Miyazaki, Hisashi Ishida, Satoshi Tanaka, Tomofumi Akasaka
Publikováno v:
Kanzo. 62:316-326
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b4858ceb203673e35f0898a0120bf6c
https://doi.org/10.2957/kanzo.62.316
https://doi.org/10.2957/kanzo.62.316
Autor:
Naho, Nishimoto, Yuko, Sakakibara, Hisashi, Ishida, Akio, Ishihara, Satoshi, Tanaka, Hiroko, Hasegawa, Shunsuke, Yamamoto, Shoichi, Nakazuru, Kiyoshi, Mori, Eiji, Mita
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 118(12)
Pembrolizumab is an immunoglobulin G4 isotype antibody that targets the programmed cell death protein 1 (PD-1) receptor of lymphocytes. It is used in the treatment of advanced non-small cell lung cancer (NSCLC). The safety and efficacy of immunothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::610d0e0224880f447133bfe92e158eeb
https://pubmed.ncbi.nlm.nih.gov/34897141
https://pubmed.ncbi.nlm.nih.gov/34897141
Publikováno v:
ACG Case Reports Journal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::548e284896a2296b82cc5e7ea1049e3d
http://europepmc.org/articles/PMC7909326
http://europepmc.org/articles/PMC7909326
Autor:
Naho Nishimoto1, Yuko Sakakibara1 sakakibara.yuko.cp@mail.hosp.go.jp, Shoichi Nakazuru1, Kiyoshi Mori2, Eiji Mita1
Publikováno v:
ACG Case Reports Journal. Feb2021, Vol. 8 Issue 2, p1-2. 2p.